mRNA vaccine shrinks childhood cancer tumors by 70% in trial
Early-stage mRNA vaccine shows significant efficacy against a deadly pediatric cancer, advancing cell therapy approaches.
SciTechDaily · +3 outlets
Moderna stock jumps 15% on drug pipeline update and CAR-T progress
Moderna announced advances in cancer pipeline, in vivo CAR-T breakthrough, and mRNA flu vaccine approval, driving investor optimism.
MSN · +8 outlets
Viridian gains FDA approval for thyroid eye disease drug Lumvoa
First-in-class veligrotug-vvze (Lumvoa) approved for thyroid eye disease across active and chronic stages, competing with Amgen's Tepezza.
FirstWord PHARMA · +8 outlets
FDA reverses course, backs Regenxbio gene therapy accelerated approval for rare disease
Regenxbio's Navsunli (LX2006) gene therapy for rare metabolic disorder receives FDA accelerated approval pathway backing after initial rejection.
MSN · +3 outlets
BridgeBio reports positive Phase 3 data for achondroplasia drug infigratinib
Oral infigratinib met Phase 3 efficacy goals in achondroplasia, with NEJM publication supporting potential regulatory approval.
Quiver Quantitative · +14 outlets
Pfizer (Merck) wins EU approval for Keytruda and Padcev combination in bladder cancer
Immunotherapy combination approved in Europe for metastatic urothelial carcinoma, expanding treatment options.
MSN · +6 outlets
FDA advisory panel recommends first mRNA flu vaccine for older adults
Moderna's mRNA flu vaccine advances toward approval, representing first in-class for elderly populations.
The Cancer Letter · +14 outlets
Roche acquires blood cancer drug for $2.3 billion from unnamed biotech
Large pharma acquisition of blood cancer asset reflects continued investment in hematologic malignancy treatments.
MSN
Psilocybin poised for FDA approval as first psychedelic therapy within months
Psychedelic-assisted therapy advancing toward potential regulatory approval, marking major policy shift in mental health treatment.
Medical Daily · +14 outlets
Novo Nordisk gains FDA approval for higher-dose Wegovy weight-loss injection
Regulatory approval for increased dosing of popular GLP-1 agonist expands therapeutic flexibility.
Stocktwits · +14 outlets
Insilico and SK Biopharmaceuticals launch up to $2.5B neuroimmune AI drug collaboration
AI-driven drug discovery partnership targets neuroimmune diseases with potential for significant upside collaboration value.
Genetic Engineering and Biotechnology Ne · +5 outlets
Gene therapy for Friedreich ataxia cardiomyopathy advances on accelerated FDA pathway
LX2006 gene therapy shows positive interim data and receives FDA accelerated approval support for rare cardiovascular condition.
Vera Health · +13 outlets
Replimune's oncolytic immunotherapy accepted for FDA review as lead program
Replimune's viral immunotherapy moves toward potential approval with FDA advisory committee review imminent.
MSN · +8 outlets
UniQure surges on plans to seek US approval for gene therapy
Gene therapy developer advances rare disease program toward FDA submission and potential market expansion.
MSN · +14 outlets
China approves first dual BAFF/APRIL therapy for IgA nephropathy
Novel immunotherapy mechanism approved in China for rare kidney disease, opening new therapeutic pathway.
The Pharma Letter · +14 outlets
Vitamin B12 analog shows promise against brain cancer in study
Novel B12-based therapy demonstrates activity in glioblastoma or similar brain malignancy, warranting further investigation.
Gulf News · +2 outlets
FDA green lights early access pathway for pancreatic cancer drug daraxonrasib
Expedited development pathway granted for protein kinase inhibitor in lethal malignancy.
MSN · +8 outlets
Anti-aging supplements tied to cancer resistance and worsened treatment outcomes
Study reveals popular supplements may paradoxically promote tumor survival and therapy resistance, raising safety questions.
MSN · +2 outlets